Sequent Scientific has moved higher by 11% to Rs 835 on the BSE after the company announced that its wholly owned subsidiary, Alivira Animal Health, has commenced the production in the Vizag facility.
The production has commenced in the Vizag facility of the wholly owned subsidiary Alivira Animal Health Limited effective from February 04, 2016 post receipt of clearance from the Andhra Pradesh Pollution Control Board after the necessary inspections were completed, Sequent Scientific said in a statement.
Alivira has state-of-the-art API manufacturing facility at Vizag with a present production of 1,000 MT with scalable capacities.
Alivira is one of the world's leading producers of Animal Health APIs, and it is gradually emerging as a powerhouse in the global animal health business.
Meanwhile, the stock had underperformed the market by falling 39% in past one month as compared to 5.5% decline in the S&P BSE Sensex.
At 10:40 AM, the stock was trading at Rs 830 after hitting an intra-day low of Rs 740 on the BSE in early morning trade. Around 13,000 shares changed hands on the counter so far.
The production has commenced in the Vizag facility of the wholly owned subsidiary Alivira Animal Health Limited effective from February 04, 2016 post receipt of clearance from the Andhra Pradesh Pollution Control Board after the necessary inspections were completed, Sequent Scientific said in a statement.
Alivira has state-of-the-art API manufacturing facility at Vizag with a present production of 1,000 MT with scalable capacities.
Alivira is one of the world's leading producers of Animal Health APIs, and it is gradually emerging as a powerhouse in the global animal health business.
Meanwhile, the stock had underperformed the market by falling 39% in past one month as compared to 5.5% decline in the S&P BSE Sensex.
At 10:40 AM, the stock was trading at Rs 830 after hitting an intra-day low of Rs 740 on the BSE in early morning trade. Around 13,000 shares changed hands on the counter so far.